Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions
Status:
Completed
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies how well vandetanib works in preventing head and neck
cancer in patients with precancerous head and neck lesions. Chemoprevention is the use of
certain drugs to keep cancer from forming. The use of vandetanib may keep cancer from forming
in patients with premalignant lesions